246 related articles for article (PubMed ID: 23234478)
21. Mild Thalassemia Intermedia Due to Interaction of δβ-Thalassemia with Triplicated α-Globin Genes.
Payán-Pernía S; Bernal Noguera S; Rojas Rodríguez E; Serra Ferrer M; Remacha Sevilla ÁF
Hemoglobin; 2020 Jul; 44(4):294-296. PubMed ID: 32693657
[TBL] [Abstract][Full Text] [Related]
22. IVS-II-16 (G>C) (
Uçucu S; Karabıyık T; Azik FM
Hemoglobin; 2021 Jul; 45(4):225-227. PubMed ID: 34396882
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the HBB: c.*233G > C Variant: No Evidence of a β-Thalassemic Phenotype.
Smith DL; Mitui M; Park JY; Luu HS; Timmons CF
Hemoglobin; 2016; 40(1):25-8. PubMed ID: 26524961
[TBL] [Abstract][Full Text] [Related]
24. Mild β(+)-thalassemia associated with two linked sequence variants: IVS-II-839 (T>C) and IVS-II-844 (C>A).
Waye JS; Eng B; Hellens L; Hohenadel BA; Nakamura LM; Walker L
Hemoglobin; 2013; 37(4):378-86. PubMed ID: 23651435
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of β-thalassemia mutations in Hatay, Turkey: reporting three new mutations.
Aldemir O; Izmirli M; Kaya H
Hemoglobin; 2014; 38(5):325-8. PubMed ID: 25155404
[TBL] [Abstract][Full Text] [Related]
26. Mutations associated with beta-thalassemia intermedia in Kuwait.
Adekile A; Haider M; Kutlar F
Med Princ Pract; 2005; 14 Suppl 1():69-72. PubMed ID: 16103715
[TBL] [Abstract][Full Text] [Related]
27. THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele.
Schmugge M; Waye JS; Basran RK; Zurbriggen K; Frischknecht H
Hemoglobin; 2008; 32(3):303-7. PubMed ID: 18473247
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of beta-thalassemia in the Dohuk region of Iraq.
Al-Allawi NA; Jubrael JM; Hughson M
Hemoglobin; 2006; 30(4):479-86. PubMed ID: 16987803
[TBL] [Abstract][Full Text] [Related]
29. Co-inheritance of hemoglobin D and β-thalassemia traits in three Iranian families: clinical relevance.
Taghavi Basmanj M; Karimipoor M; Amirian A; Jafarinejad M; Katouzian L; Valaei A; Bayat F; Kordafshari A; Zeinali S
Arch Iran Med; 2011 Jan; 14(1):61-3. PubMed ID: 21194265
[TBL] [Abstract][Full Text] [Related]
30. Molecular update of β-thalassemia mutations in the Syrian population: identification of rare β-thalassemia mutations.
Jarjour RA; Murad H; Moasses F; Al-Achkar W
Hemoglobin; 2014; 38(4):272-6. PubMed ID: 24828949
[TBL] [Abstract][Full Text] [Related]
31. Genotype and phenotype characterizations in a large cohort of β-thalassemia heterozygote with different forms of α-thalassemia in northeast Thailand.
Yamsri S; Sanchaisuriya K; Fucharoen G; Sae-Ung N; Fucharoen S
Blood Cells Mol Dis; 2011 Aug; 47(2):120-4. PubMed ID: 21664157
[TBL] [Abstract][Full Text] [Related]
32. A single nucleotide polymorphism in the HBBP1 gene in the human β-globin locus is associated with a mild β-thalassemia disease phenotype.
Giannopoulou E; Bartsakoulia M; Tafrali C; Kourakli A; Poulas K; Stavrou EF; Papachatzopoulou A; Georgitsi M; Patrinos GP
Hemoglobin; 2012; 36(5):433-45. PubMed ID: 22943111
[TBL] [Abstract][Full Text] [Related]
33. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.
Kolliopoulou A; Siamoglou S; John A; Sgourou A; Kourakli A; Symeonidis A; Vlachaki E; Chalkia P; Theodoridou S; Ali BR; Katsila T; Patrinos GP; Papachatzopoulou A
Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620
[TBL] [Abstract][Full Text] [Related]
34. β-Thalassemia major resulting from compound heterozygosity for HBB: c.92+2T>C [formerly known as IVS-I-2 (T>C)] and a novel β(0)-thalassemia frameshift mutation: HBB: c.209delG; p.Gly70Valfs*20.
Kluge ML; Hoyer JD; Swanson KC; Oliveira JL
Hemoglobin; 2014; 38(4):292-4. PubMed ID: 24986053
[TBL] [Abstract][Full Text] [Related]
35. [Beta(+)-thalassemia (-31CapA-->G) homozygosity discovered on the mass medical examination: diagnosis for beta-thalassemia and DNA analysis].
Orisaka M; Koyamada K; Suzuki Z; Itoh T; Harano K; Harano T
Rinsho Byori; 1998 Mar; 46(3):259-64. PubMed ID: 9564765
[TBL] [Abstract][Full Text] [Related]
36. Genotype/Phenotype Correlation of β-Thalassemia in Syrian Patients: A Cross-Sectional Study.
Shoujaa A; Moasses F; Mukhalalaty Y; Murad H; Al-Quobaili F
Hemoglobin; 2020 Jan; 44(1):42-46. PubMed ID: 31903828
[TBL] [Abstract][Full Text] [Related]
37. Lack of association of G779A ZHX-2 gene variant with HbF levels in β-thalassemia major.
Munshi A; Dadheech S; Jain S; Joseph J; Al-Hazzani A; Alshatwi AA; Sai Babu M; Rajeshwar K; Jyothy A
Eur J Haematol; 2011 Jun; 86(6):502-6. PubMed ID: 21443521
[TBL] [Abstract][Full Text] [Related]
38. New Insights on β-Thalassemia in the Palestinian Population of Gaza: High Frequency and Milder Phenotype Among Homozygous IVS-I-1 (HBB: c.92+1G>A) Patients with High Levels of Hb F.
Ghoti H; Fibach E; Rachmilewitz EA; Jeadi H; Filon D
Hemoglobin; 2017 Mar; 41(2):144-146. PubMed ID: 28670942
[TBL] [Abstract][Full Text] [Related]
39. β-Thalassemia mutations in Western India: outcome of prenatal diagnosis in a hemoglobinopathies project.
Patel AP; Patel RB; Patel SA; Vaniawala SN; Patel DS; Shrivastava NS; Sharma NP; Zala JV; Parmar PH; Naik MR
Hemoglobin; 2014; 38(5):329-34. PubMed ID: 25222044
[TBL] [Abstract][Full Text] [Related]
40. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]